FOIA records portray repeated shouting, slammed doors and gaming at Wayne State's School of Medicine; investigators said they found no conclusive policy violations.

Ann Arbor-based Esperion agreed to be acquired by ARCHIMED for $3.16 per share plus potential milestone payments, valuing the firm up to $1.1 billion.

More than 100 civic, business and philanthropic leaders met at Focus: HOPE to unpack Detroit Future City's new 'Tech Tomorrow' report and map equity-first tech growth. The report forecasts 20,000 jobs and $6.8B in wages if investments hold.

Topline Phase 3 results show daraxonrasib extended median survival to 13.2 months versus 6.7 months for chemo, offering fresh hope in a brutal disease. Full safety and subgroup data are still pending.

A Manhattan ruling in February has spurred law‑firm advisories and contract changes after judges found consumer AI chats can be discoverable. Lawyers are urging enterprise tools and stricter prompts.

Ann Arbor startup Sygaldry secured $139M to build quantum-accelerated AI servers that promise faster model training and lower energy use.

Gallup’s latest workforce poll finds rising AI adoption, but about half of U.S. employees use AI only rarely or not at all, citing ethics, privacy and job concerns.

MSU is unifying its MD and DO schools and anchoring new research and clinical investments in Detroit and Grand Rapids. The plan centralizes leadership while preserving degree pathways.

MSU researchers published a Cell paper describing GPS, an AI platform that produced preclinical compound leads for liver cancer and pulmonary fibrosis and released the code and portal.

A 24‑year‑old man became the first patient in Michigan to receive Lyfgenia, a one‑time gene therapy for sickle cell disease, at Children’s Hospital of Michigan.

A suspected Iran‑linked cyberattack plunged Stryker into a global outage on March 11, locking staff out of systems and wiping some devices. Memphis offices are among those connected to the disruption.

A University of Michigan meta‑analysis finds human noise is disrupting bird behavior and lowering reproductive success — and researchers say simple fixes can help.

Henry Ford Health gave the state’s first off‑trial infusion of ROCTAVIAN on Jan. 15, using a one‑time gene therapy that could replace years of costly prophylaxis. The treatment and its $2.8M+ drug price raise difficult trade‑offs for patients and payers.